期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

生物药剂学分类系统及其应用(下) 被引量：5

下载PDF
导出
摘要 2．2 在药品开发领域的应用 自20世纪60年代以来，人们越来越认识到口服吸收过程中药物在胃肠道溶出以及在肠壁上通透的重要性。近年来，许多用于建立BCS的研究已为新药开发尤其在药物通透性领域，提供了重要的定量数据。具体地说，BCS还在筛选候选药物进行全面开发、剂型选择、固体制剂溶出度试验体内外相关的可能性及预测并阐述与食物的相互作用等方面具有重要意义。
作者 斯陆勤 黄建耿 李高
机构地区 华中科技大学同济医学院药学院
出处 《中国药师》 CAS 2008年第2期163-166,共4页 China Pharmacist
关键词 生物药剂学分类系统 溶解性 通透性 应用
分类号 R945 [医药卫生—微生物与生化药学]
  • 相关文献

参考文献17

  • 1何仲贵.药物生物利用度[M].北京.化学工业出版社,2006.391-411
  • 2Guidance for industry, Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceatics Classification System[S]. August 2000, CDER/FDA
  • 3Note for Guidance on the Investigation of Bioavailability and Bioequivalence (CPMP/EWP/QWP/1401/98 DRAFT)
  • 4Lobenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards[J]. European Journal of pharmaceutics and biopharmaceutics, 2000,50(1):3-12
  • 5Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system [J]. Eur J Pharm Biopharm, 2004,58(2):265-278
  • 6Kasim NA, Whitehouse M, Ramachandran C, et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification [J].Mol Pharmacol, 2004,1(1):85-96
  • 7Oh DM, Curl RL, Amidon GL. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans:a mathematical model[J]. Pharm Res, 1993,10(2):264-270
  • 8Yu LX, Amidon GL, Polli JE, et al. Biopharmaceutics Classification System:The Scientific Basisfor Biowaiver Extensions[J]. Pharm Res,2002,19(7):921-925
  • 9Wacher VJ, Salphati L, and Benet LZ. Active secretion and enterocytic drug metabolism barriers to drug absorption[J].Adv.Drug Deliv. Rev. 2001,46(1-3):89-102
  • 10Bergstrom CA, Norinder U, Luthman K, et al. Experimental and computational screening models for prediction of aqueous drug solubility[J]. Pharm Res, 2002,19(2):182-188

二级参考文献21

  • 1FAASSEN F,VROMANS H.Biowaivers for oral immediate-release products:implications of linear pharmacokinetics[J].Clin Pharmacokinet,2004,43 (15):1117-1126.
  • 2KASIM NA,WHITEHOUSE M,RAMACHANDRAN C,et al.Molecular properties of WHO essential drugs and provisional biopharmaceutical classification[J].Mol Pharmacol,2004,1 (1):85-96.
  • 3SIKRI V,PAL D,JAIN R,et al.Cotransport of macrolide and fluoroquinolones,a beneficial interaction reversing P-glycoprotein efflux[J].Am J Ther,2004,11 (6):433 -442.
  • 4MEALEY KL.Therapeutic implications of the MDR-1 gene[J].J Vet Pharmacol Ther,2004,27 (5):257-264
  • 5SHA X,YAN G,WU Y,et al.Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2cells[J].Eur J Pharm Sci,2005,24(5):477-486.
  • 6IZZEDINE H,LAUNARY VV,DERAY G.Renal tubular transporters and antiviral drugs:an update.[J].AIDS,2005,19 (5):455-462.
  • 7BOSTROM M,NINHAM BW.Energy of an ion crossing a low dielectric membrane:the role of dispersion self-free energy[J].Biophy Chem,2005,114(2-3):95 -101.
  • 8PASTOR AM,CANO SP,MOLINA-AREAS M,et al.Cell entry and export of nucleoside analogues[J].Virus Res,2005,107 (2):151-164.
  • 9SAI Y.Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition[J].Drug Metab Pharmacokinet,2005,20 (2):91-99.
  • 10SON DO,SATSU H,KISO Y,et al.Characterization of carnosine uptake and its physiological function in human intestinal epithelial Caco-2 cells[J].Biofactors,2004,21 (1-4):395-398.

共引文献1

同被引文献37

引证文献5

二级引证文献7

中国药师
2008年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部